Cited by 1,573Schizophrenia research and treatmentPsychological Testing and AssessmentMental Health and Psychiatry

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Keefe, R·2004·Schizophrenia Research

DOI 10.1016/j.schres.2003.09.011

Open this paper in CoChat — free account

Abstract

Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2003.09.011

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Untitled work
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617

Flagged first, then by citations

Show all 27 references

2 of the 27 references couldn’t be matched to a known paper.

Sorted by citations

Items 601–700 of 1,000

Towards remote digital phenotyping of cognition in schizophrenia
Guimond, S., Keshavan, M. S., & Torous, J. B. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.04.016 · Cited by 21
Validation of the Danish version of the brief negative symptom scale
Gehr, J., Glenthoj, B. Y., & Nielsen, M. Ø. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1648549 · Cited by 21
Grey-matter abnormalities in clinical high-risk participants for psychosis
Zikidi, K., Gajwani, R., Groß, J., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Fracasso, A., & Uhlhaas, P. J. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.08.034 · Cited by 21
Enhancing supported employment services for individuals with a serious mental illness: A review of the literature
Loveland, D., Driscoll, H. P., & Boyle, M. (2007) · Journal of Vocational Rehabilitation · doi:10.3233/jvr-2007-00397 · Cited by 21
The effect of the muscarinic M 1 receptor antagonist biperiden on cognition in medication free subjects with psychosis
Vingerhoets, C., Bakker, G., Dijk, J. V., Bloemen, O., Wang, Y., Chan, R. C. K., Booij, J., & van Amelsvoort, T. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.06.014 · Cited by 21
Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity
Speyer, H., Nørgaard, H. C. B., Hjorthøj, C., Madsen, T. A., Drivsholm, S., Pisinger, C., Gluud, C., Mors, O., Krogh, J., & Nordentoft, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0465-2 · Cited by 20
Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophrenia
Welch, L. C., Trudeau, J., Silverstein, S., Sand, M., Henderson, D. C., & Rosen, R. (2017) · Patient Related Outcome Measures · doi:10.2147/prom.s123266 · Cited by 15
Deriving symptom networks from digital phenotyping data in serious mental illness
Hays, R., Keshavan, M. S., Wisniewski, H., & Torous, J. B. (2020) · BJPsych Open · doi:10.1192/bjo.2020.94 · Cited by 20
White matter microstructure across brain-based biotypes for psychosis – findings from the bipolar-schizophrenia network for intermediate phenotypes
Kelly, S., Guimond, S., Pasternak, O., Lutz, O., Lizano, P. L., Karayumak, S. C., Sweeney, J. A., Pearlson, G. D., Clementz, B. A., McDowell, J. E., et al. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111234 · Cited by 20
Validation of an ecological momentary assessment to measure processing speed and executive function in schizophrenia
Shvetz, C., Gu, F., Drodge, J., Torous, J. B., & Guimond, S. (2021) · Schizophrenia · doi:10.1038/s41537-021-00194-9 · Cited by 20
Web-Based Cognitive Testing in Psychiatric Research: Validation and Usability Study
Lynham, A. J., Jones, I. R., & Walters, J. (2022) · Journal of Medical Internet Research · doi:10.2196/28233 · Cited by 18
Sex Differences in Social Cognition and Association of Social Cognition and Neurocognition in Early Course Schizophrenia
Kubota, R., Okubo, R., Ikezawa, S., Matsui, M., Adachi, L., Wada, A., Fujimaki, C., Yamada, Y., Saeki, K., Sumiyoshi, C., et al. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.867468 · Cited by 20
Self-report versus performance based executive functioning in people with psychotic disorders
van Aken, B. C., Rietveld, R., Wierdsma, A. I., Voskes, Y., Pijnenborg, G. H. M., van Weeghel, J., & Mulder, C. L. (2023) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2023.100293 · Cited by 21
The Relationship Between Level of Education, Cognitive Function and Medication Adherence in Patients with Schizophrenia
Zhu, X., Wen, M., Hé, Y., Feng, J., Xu, X., & Liu, J. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s424694 · Cited by 32
Digital phenotyping correlates of mobile cognitive measures in schizophrenia: A multisite global mental health feasibility trial
Cohen, A., Joshi, D., Bondre, A. P., Chand, P., Chaturvedi, N., Choudhary, S., Dutt, S., Khan, A., Langholm, C., Kumar, M., et al. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000526 · Cited by 20
Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement
Sehatpour, P., & Kantrowitz, J. T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.08.019 · Cited by 21
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Takekita, Y., Koshikawa, Y., Fabbri, C., Sakai, S., Sunada, N., Onohara, A., Nishida, K., Yoshimura, M., Kato, M., Serretti, A., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0883-9 · Cited by 21
Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia
García-Álvarez, L., García‐Portilla, M. P., González-Blanco, L., Sáiz, P. A., de la Fuente-Tomás, L., Menéndez-Miranda, I., García, C. I., & Bobes, J. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.04.003 · Cited by 20
Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia
Akiyama, K., Saitô, S., Saito, A., Ozeki, Y., Watanabe, T., Fujii, K., Honda, G., & Shimoda, K. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.070 · Cited by 20
Investigation of sleep spindle activity and morphology as predictors of neurocognitive functioning in medicated patients with schizophrenia
Baandrup, L., Christensen, J. A. E., Fagerlund, B., & Jennum, P. (2018) · Journal of Sleep Research · doi:10.1111/jsr.12672 · Cited by 20
The role of premorbid adjustment in schizophrenia: Focus on cognitive remediation outcome
Buonocore, M., Bosinelli, F., Bechi, M., Spangaro, M., Piantanida, M., Cocchi, F., Bianchi, L., Guglielmino, C., Mastromatteo, A. R., Cavallaro, R., et al. (2018) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2018.1433048 · Cited by 21
The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
Atake, K., Nakamura, T., Ueda, N., Hori, H., Katsuki, A., & Yoshimura, R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00232 · Cited by 23
Effect of cognitive function on jumping to conclusion in patients with schizophrenia
Takeda, T., Nakataki, M., Ohta, M., Hamatani, S., Matsuura, K., & Ohmori, T. (2018) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2018.04.002 · Cited by 20
Predicting work outcome in patients with schizophrenia: Influence of IQ decline
Sumiyoshi, C., Fujino, H., Yamamori, H., Kudo, N., Azechi, H., Fujimoto, M., Yasuda, Y., Ohi, K., Sumiyoshi, T., & Hashimoto, R. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.042 · Cited by 20
Cognitive Function Is Impaired in Patients with Recently Diagnosed Type 2 Diabetes, but Not Type 1 Diabetes
van Gemert, T., Wölwer, W., Weber, K. S., Hoyer, A., Straßburger, K., Bohnau, N. T., Brüggen, M. A., Ovelgönne, K., Gössmann, E.-M., Burkart, V., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1470476 · Cited by 20
Defining cognitive profiles of depressive patients using the Brief Assessment of Cognition in Affective Disorders
Chen, R.-A., Lee, C., Lee, Y., Hung, C., Huang, Y., Lin, P., Lee, S.-Y., & Wang, L. (2019) · PeerJ · doi:10.7717/peerj.7432 · Cited by 20
Focusing on recovery goals improves motivation in first-episode psychosis
Fulford, D., Meyer-Kalos, P., & Mueser, K. T. (2020) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-020-01877-x · Cited by 20
Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks
Moran, E. K., Gold, J. M., Carter, C. S., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., Luck, S. J., & Barch, D. M. (2020) · Psychological Medicine · doi:10.1017/s003329172000286x · Cited by 19
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
Matrone, M., Kotzalidis, G. D., Romano, A., Bozzao, A., Cuomo, I., Valente, F., Gabaglio, C., Lombardozzi, G., Trovini, G., Amici, E., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110493 · Cited by 20
Psychological approaches to understanding and promoting recovery in psychosis and bipolar disorder: a mixed-methods approach
Morrison, A. P., Law, H., Barrowclough, C., Bentall, R. P., Haddock, G., Jones, S. H., Kilbride, M., Pitt, E., Shryane, N. M., Tarrier, N., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04050 · Cited by 24
Applicability of the MATRICS Consensus Cognitive Battery in Singapore
Rapisarda, A., Lim, T. F., Lim, M., Collinson, S. L., Kraus, M., & Keefe, R. S. E. (2013) · The Clinical Neuropsychologist · doi:10.1080/13854046.2012.762120 · Cited by 19
Healthy Adolescent Performance With Standardized Scoring Tables for the MATRICS Consensus Cognitive Battery: A Multisite Study
Smelror, R. E., Jørgensen, K. N., Lonning, V., Kelleher, I., Cannon, M. D., DeRosse, P., Malhotra, A. K., Karlsgodt, K. H., Andreassen, O. A., Lundberg, M., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby131 · Cited by 19
Performance on the Wechsler Adult Intelligence Scale (WAIS ) in Japanese patients with bipolar and major depressive disorders in euthymic and depressed states
Matsuo, J., Hori, H., Ishida, I., Hiraishi, M., Ota, M., Hidese, S., Yomogida, Y., & Kunugi, H. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13191 · Cited by 19
Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder
Zhou, Q., Lv, X., Zhou, S., Liu, Q., Tian, H., Zhang, K., Wei, J., Wang, G., Chen, Q., Zhu, G., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114202 · Cited by 19
A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits
Zhao, Q., Cao, H., Zhang, W., Li, S., Xiao, Y., Tamminga, C. A., Keshavan, M. S., Pearlson, G. D., Clementz, B. A., Gershon, E. S., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01300-w · Cited by 19
Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis
Miskowiak, K. W., Kjærstad, H. L., Lemvigh, C. K., Ambrosen, K. S., Thorvald, M. S., Kessing, L. V., Glenthoj, B. Y., Ebdrup, B. H., & Fagerlund, B. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.025 · Cited by 19
Probiotic Formulation for Patients With Bipolar or Schizophrenia Spectrum Disorder: A Double-Blind, Randomized Placebo-Controlled Trial
Borkent, J., Ioannou, M., Neijzen, D., Haarman, B. C. M., & Sommer, I. E. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae188 · Cited by 24
Predictors of Change in Functional Competence and Functional Behavior After Functional Adaptation Skills Training for Schizophrenia
Gupta, M., Holshausen, K., Mausbach, B. T., Patterson, T. L., & Bowie, C. R. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182613f79 · Cited by 19
Deficits of cognitive theory of mind and its relationship with functioning in individuals with an at-risk mental state and first-episode psychosis
Ohmuro, N., Katsura, M., Obara, C., Kikuchi, T., Sakuma, A., Iizuka, K., Hamaie, Y., Ito, F., Matsuoka, H., & Matsumoto, K. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.06.051 · Cited by 19
Neurocognitive and theory of mind deficits and poor social competence in schizophrenia: The moderating role of social disinterest attitudes
Le, T. P., Holden, J. L., Link, P. C., & Granholm, E. L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.10.011 · Cited by 19
Effect of adding individualized occupational therapy to standard care on rehospitalization of patients with schizophrenia: A 2‐year prospective cohort study
Shimada, T., Ohori, M., Inagaki, Y., Shimooka, Y., Ishihara, I., Sugimura, N., Tanaka, S., & Kobayashi, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12858 · Cited by 19
European violence risk and mental disorders (EU-VIORMED): a multi-centre prospective cohort study protocol
de Girolamo, G., Carrà, G., Fangerau, H., Ferrari, C., Gosek, P., Heitzman, J., Salize, H. J., Walker, M. M., Wancata, J., & Picchioni, M. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2379-x · Cited by 22
The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis
de Vos, C., Leopold, K., Blanke, E. S., Siebert, S., Baumgardt, J., Burkhardt, E., & Bechdolf, A. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113424 · Cited by 19
Features of Duration Mismatch Negativity Around the Onset of Overt Psychotic Disorders: A Longitudinal Study
Tateno, T., Higuchi, Y., Nakajima, S., Sasabayashi, D., Nakamura, M., Ueno, M., Mizukami, Y., Nishiyama, S., Takahashi, T., Sumiyoshi, T., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa364 · Cited by 19
Effects of aerobic walking on cognitive function in patients with schizophrenia: A randomized controlled trial
Huang, Y., Hung, C., Hsu, S., Lin, P., Lee, Y., Chong, M., Chen, C.-C., Kuo, Y., & Wang, L. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.062 · Cited by 24
The Interplay between Vitamin D, Exposure of Anticholinergic Antipsychotics and Cognition in Schizophrenia
Gaebler, A. J., Finner‐Prével, M., Sudar, F. P., Langer, F. H., Keskin, F., Gebel, A., Zweerings, J., & Mathiak, K. (2022) · Biomedicines · doi:10.3390/biomedicines10051096 · Cited by 19
Effects of biasing the location of stimulus presentation, and the muscarinic cholinergic receptor antagonist scopolamine, on performance of a 5-choice serial reaction time attention task in rats
Shannon, H. E., & Eberle, E. L. (2005) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000189813.54178.e3 · Cited by 19
Do Symptoms and Cognitive Problems Affect the Use and Efficacy of a Web-Based Decision Support System for Smokers With Serious Mental Illness?
Ferron, J. C., Brunette, M. F., McGurk, S. R., Xie, H., Frounfelker, R. L., Cook, J. Α., Jonikas, J. A., & McHugo, G. J. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.723316 · Cited by 20
Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features
Nitzburg, G. C., Burdick, K. E., Malhotra, A. K., & DeRosse, P. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2014.12.003 · Cited by 19
Refining the latent structure of neuropsychological performance in schizophrenia
Lam, M., Collinson, S. L., Eng, G. K., Rapisarda, A., Kraus, M., Lee, J., Chong, S. A., & Keefe, R. S. E. (2014) · Psychological Medicine · doi:10.1017/s0033291714001020 · Cited by 19
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia.
Buonocore, M., Bosia, M., Bechi, M., Spangaro, M., Cavedoni, S., Cocchi, F., Guglielmino, C., Bianchi, L., Mastromatteo, A. R., & Cavallaro, R. (2017) · Neuropsychology · doi:10.1037/neu0000347 · Cited by 19
Eye gaze perception in bipolar disorder: Self‐referential bias but intact perceptual sensitivity
Yao, B., Mueller, S. A., Grove, T. B., McLaughlin, M. M., Thakkar, K. N., Ellingrod, V. L., McInnis, M. G., Taylor, S. F., Deldin, P. J., & Tso, I. F. (2017) · Bipolar Disorders · doi:10.1111/bdi.12564 · Cited by 19
P300 event-related potential in abstinent methamphetamine-dependent patients
Haifeng, J., Zhuang, W., Hong, C., Chuanwei, L., Du, J., Haiming, S., Chen, Z., Din, X., Jijun, W., & Zhao, M. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.003 · Cited by 19
A decline in self-defining memories following a diagnosis of schizophrenia
Holm, T., Pillemer, D. B., Bliksted, V., & Thomsen, D. K. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.03.014 · Cited by 18
Brief Screening for Executive Dysfunction in Schizophrenia in a Rehabilitation Hospital
Power, B., Dragović, M., & Rock, D. J. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11060145 · Cited by 18
Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
Weickert, T. W., & Weickert, C. S. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00202 · Cited by 18
Early childhood social communication deficits in youth at clinical high-risk for psychosis: Associations with functioning and risk
Osborne, K. J., Vargas, T., & Mittal, V. A. (2019) · Development and Psychopathology · doi:10.1017/s0954579419000385 · Cited by 19
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia
Francis, M., Hummer, T. A., Liffick, E., Vohs, J. L., Mehdiyoun, N. F., Visco, A. C., Yang, Z., Kovacs, R. J., Zhang, Y., & Breier, A. F. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00375-7 · Cited by 17
Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2)
Huang, L.-Y., Jackson, B. S., Rodrigue, A., Tamminga, C. A., Gershon, E. S., Pearlson, G. D., Keshavan, M. S., Keedy, S., Hill, S. K., Sweeney, J. A., et al. (2021) · Psychological Medicine · doi:10.1017/s003329172000478x · Cited by 18
Global Examination of Mental State: An open tool for the brief evaluation of cognition
Mondini, S., Montemurro, S., Pucci, V., Ravelli, A., Signorini, M., & Arcara, G. (2022) · Brain and Behavior · doi:10.1002/brb3.2710 · Cited by 18
The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder
van Boxel, R., Gangadin, S. S., Janssen, H., van der Steur, S. J., van der Vinne, L. J. C., Dortants, L., Pelgrim, T. A. D., Draisma, L. W. R., Tuura, R., van der Meer, P. B., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.019 · Cited by 18
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Vita, A., Barlati, S., Cavallaro, R., Mucci, A., Riva, M. A., Rocca, P., Rossi, A., & Galderisi, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1451832 · Cited by 28
Sensitivity and applicability of the Brazilian version of the Brief Assessment of Cognition in Schizophrenia (BACS)
Salgado, J. V., Carvalhaes, C. F. R., Pires, A. D. M., das Neves, M. D. C. L., Cruz, B. F., Cardoso, C. S., Lauar, H., Teixeira, A. L., & Keefe, R. S. E. (2007) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642008dn10300007 · Cited by 18
Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder
Vita, A., Deste, G., Barlati, S., Poli, R., Cacciani, P., Peri, L. M. D., & Sacchetti, E. (2016) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2016.1148054 · Cited by 18
Relationship of Metacognition and Insight to Neural Synchronization and Cognitive Function in Early Phase Psychosis
Leonhardt, B. L., Vohs, J. L., Bartolomeo, L. A., Visco, A. C., Hetrick, W. P., Bolbecker, A. R., Breier, A. F., Lysaker, P. H., & O’Donnell, B. F. (2019) · Clinical EEG and Neuroscience · doi:10.1177/1550059419857971 · Cited by 18
Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B–SNIP) cohort
Massa, N., Owens, A. V., Harmon, W., Bhattacharya, A., Ivleva, E. I., Keedy, S., Sweeney, J. A., Pearlson, G. D., Keshavan, M. S., Tamminga, C. A., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.013 · Cited by 18
Examining Potential Barriers to mHealth Implementation and Engagement in Schizophrenia: Phone Ownership and Symptom Severity
Luther, L., Buck, B., Fischer, M. W., Johnson-Kwochka, A. V., Coffin, G., & Salyers, M. P. (2020) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-020-00162-7 · Cited by 18
Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls
Hamilton, H., Roach, B. J., & Mathalon, D. H. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.10.010 · Cited by 18
Generalized neurocognitive impairment in individuals at ultra‐high risk for psychosis: The possible key role of slowed processing speed
Randers, L., Jepsen, J. R. M., Fagerlund, B., Nordholm, D., Krakauer, K., Hjorthøj, C. R., Glenthoj, B. Y., & Nordentoft, M. (2021) · Brain and Behavior · doi:10.1002/brb3.1962 · Cited by 17
The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disorders
Oomen, P. P., Gangadin, S. S., Begemann, M., Visser, E., Mandl, R. C. W., & Sommer, I. E. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.006 · Cited by 18
New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function
Uehara, T., Sumiyoshi, T., & Kurachi, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666151009120153 · Cited by 18
Manual Dexterity in Schizophrenia—A Neglected Clinical Marker?
Térémetz, M., Carment, L., Brénugat-Herné, L., Croca, M., Bleton, J., Krebs, M., Maier, M. A., Amado, I., & Lindberg, P. G. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00120 · Cited by 18
Ineffective initiation contributes to deficient verbal and non-verbal fluency in patients with schizophrenia
Krukow, P., Harciarek, M., Morylowska-Topolska, J., Karakuła‐Juchnowicz, H., & Jonak, K. (2017) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2017.1356710 · Cited by 18
Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
Sugawara, N., Yasui‐Furukori, N., & Sumiyoshi, T. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00195 · Cited by 20
Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study
Wittorf, A., Sickinger, S., Wiedemann, G., & Klingberg, S. (2008) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2007.12.005 · Cited by 18
Evaluating the utility of digital phenotyping to predict health outcomes in schizophrenia: protocol for the HOPE-S observational study
Rashid, N. A. A., Martanto, W., Yang, Z., Wang, X., Heaukulani, C., Vouk, N., Buddhika, T., Wei, Y., Verma, S. K., Tang, C. Y. Z., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046552 · Cited by 18
Hippocampal structural alterations in early-stage psychosis: Specificity and relationship to clinical outcomes
Brunner, G., Gajwani, R., Groß, J., Gumley, A. I., Krishnadas, R., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Fracasso, A., & Uhlhaas, P. J. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103087 · Cited by 17
Identifying psychiatric manifestations in schizophrenia and depression from audio-visual behavioural indicators through a machine-learning approach
Xu, S., Yang, Z., Chakraborty, D., Chua, Y. H. V., Tolomeo, S., WINKLER, S. S., Birnbaum, M., Tan, B., Lee, J., & Dauwels, J. (2022) · Schizophrenia · doi:10.1038/s41537-022-00287-z · Cited by 17
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
Hidese, S., Yoshida, F., Ishida, I., Matsuo, J., Hattori, K., & Kunugi, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12304 · Cited by 16
In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis on Health-Related Quality of Life and Disabilities Are Partly Mediated by Generalized Cognitive Decline and the Symptomatome
Al-Musawi, A. F., Al‐Hakeim, H. K., AlKhfaji, Z. A., Al-Haboby, I. H., Almulla, A. F., Stoyanov, D., & Maes, M. H. J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192215281 · Cited by 17
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia
Garofalo, M., Simone, G. D., Motta, Z., Nuzzo, T., Grandis, E. D., Bruno, C., Boeri, S., Riccio, M. P., Pastore, L., Bravaccio, C., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1408175 · Cited by 16
Carbon monoxide feedback in a motivational decision support system for nicotine dependence among smokers with severe mental illnesses
Brunette, M. F., Ferron, J. C., Drake, R. E., Devitt, T. S., Geiger, P., McHugo, G. J., Jonikas, J. A., & Cook, J. Α. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.04.005 · Cited by 17
Association between the scores of the Japanese version of the Brief Assessment of Cognition in Schizophrenia and whole‐brain structure in patients with chronic schizophrenia: A voxel‐based morphometry and diffusion tensor imaging study
Hidese, S., Ota, M., Matsuo, J., Ishida, I., Hiraishi, M., Teraishi, T., Hattori, K., & Kunugi, H. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12560 · Cited by 17
Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
Chen, C., Lee, C., Lee, Y., Hung, C., Huang, Y., Lee, S.-Y., Huang, M., Chong, M., Chen, Y., & Wang, L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.062 · Cited by 17
Poor functional recovery is better predicted than conversion in studies of outcomes of clinical high risk of psychosis: insight from SHARP
Zhang, T., Yang, S., Xu, L., Tang, X., Wei, Y., Cui, H., Li, H., Tang, Y., Hui, L., Li, C., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719002174 · Cited by 17
Computer-assisted cognitive remediation therapy for patients with schizophrenia induces microstructural changes in cerebellar regions involved in cognitive functions
Matsuoka, K., Morimoto, T., Matsuda, Y., Yasuno, F., Taoka, T., Miyasaka, T., Yoshikawa, H., Takahashi, M., Kitamura, S., Kichikawa, K., et al. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.09.001 · Cited by 19
Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand
Srisurapanont, M., Lamyai, W., Pono, K., Indrakamhaeng, D., Saengsin, A., Songhong, N., Khuwuthyakorn, P., & Jantamo, P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107961 · Cited by 17
Increased Plasma Level of Longevity Protein Klotho as a Potential Indicator of Cognitive Function Preservation in Patients With Schizophrenia
Xiong, J., Zhan, J., Luo, T., Chen, H., Wan, Q., Wang, Y., Wei, B., & Yang, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00610 · Cited by 17
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role?
Spangaro, M., Martini, F., Bechi, M., Buonocore, M., Agostoni, G., Cocchi, F., Sapienza, J., Bosia, M., & Cavallaro, R. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.07.019 · Cited by 17
Transcranial Direct Current Stimulation on the Left Superior Temporal Sulcus Improves Social Cognition in Schizophrenia: An Open-Label Study
Yamada, Y., Sueyoshi, K., Yokoi, Y., Inagawa, T., Hirabayashi, N., Oi, H., Shirama, A., & Sumiyoshi, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.862814 · Cited by 17
Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment
Poletti, S., Papa, G. S., Locatelli, C., Colombo, C., & Benedetti, F. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.023 · Cited by 17
Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study
Ohta, M., Nakataki, M., Takeda, T., Numata, S., Tominaga, T., Kameoka, N., Kubo, H., Kinoshita, M., Matsuura, K., Otomo, M., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s163132 · Cited by 17
Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis
Hudgens‐Haney, M. E., Clementz, B. A., Ivleva, E. I., Keshavan, M. S., Pearlson, G. D., Gershon, E. S., Keedy, S., Sweeney, J. A., Gaudoux, F., Bunouf, P., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa001 · Cited by 18
Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)
Araújo, G. E., Brandão‐de‐Resende, C., Cardoso, A. C. A., Teixeira, A. L., Keefe, R. S. E., & Salgado, J. V. (2015) · Clinics · doi:10.6061/clinics/2015(04)10 · Cited by 17
Treatment-refractory schizophrenia
Buckley, P. F., & Shendarkar, N. (2005) · Current Opinion in Psychiatry · doi:10.1097/00001504-200503000-00010 · Cited by 18
Effects of kynurenine pathway metabolites on choroid plexus volume, hemodynamic response, and spontaneous neural activity: A new mechanism for disrupted neurovascular communication and impaired cognition in mood disorders
Bravi, B., Verga, C., Palladini, M., Sara, P., Camilla, B., Sut, S., Dall’Acqua, S., Colombo, C., Comai, S., & Benedetti, F. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.025 · Cited by 18
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity
Caporusso, E., Melillo, A., Perrottelli, A., Giuliani, L., Marzocchi, F. F., Pezzella, P., & Giordano, G. M. (2025) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2025.1543005 · Cited by 19
Assessing cognition in people with severe mental disorders in low- and middle-income countries: a systematic review of assessment measures
Haile, Y. G., Habatmu, K., Derese, A., Gouse, H., Lawrie, S. M., Cella, M., & Alem, A. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02120-x · Cited by 17
White matter in prolonged glucocorticoid response to psychological stress in schizophrenia
Goldwaser, E. L., Chiappelli, J., Kvarta, M. D., Du, X. M., Millman, Z. B., Adhikari, B. M., O’Neill, H., Sewell, J., Lightner, S., Vodapalli, S., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01077-4 · Cited by 17
Brief battery of the Social Cognition Psychometric Evaluation study (BB-SCOPE): Development and validation in schizophrenia spectrum disorders
Halverson, T. F., Pinkham, A. E., Harvey, P. D., & Penn, D. L. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.03.017 · Cited by 16

Authors: Keefe, R.
Affiliations: Duke University (US)
Corresponding author: Keefe, R
ORCID: Keefe, R
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2004-06-01
Volume: 68
Issue: 2-3
Pages: 283-297
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2003.09.011
OpenAlex: W2008062633
Cited by: 1,573
References: 27
Citations by year: 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
FWCI: 4.09
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: Brief Assessment of Cognition in Schizophrenia, schizophrenia
MeSH terms: Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks